November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Niklas Klümper: Happy to share our commentary about EV-302
Apr 12, 2024, 12:37

Niklas Klümper: Happy to share our commentary about EV-302

Niklas Klümper, Resident in Urology and Researcher at the Institute for Experimental Oncology at the University Hospital Bonn, shared on X/Twitter:

“Happy to share our commentary about EV-302 in Journal of European Urology.
– Thanks to Markus Eckstein, Boris Hadaschik and Viktor Grünwald.

Identification of patients with low or minimal chances of benefiting from EV/P is crucial, as there are other effective therapies available (eg, chemoimmunotherapy) or in late-stage clinical development.

Loss of target protein NECTIN4 is an intuitive predictive biomarker. Close correlation between ADC target and response is well-established (eg, Her2-ADC).

We believe that assessment of NECTIN4 status will help in achieving optimal integration of EV/P into standard of care!”

Proceed to the article.
Source: Niklas Klümper/X